Chronic kidney disease (CKD) severity is associated with an increased risk for gastroparesis, according to a study published ...

Credit: Getty Images The KDIGO 2024 chronic kidney disease guideline replaces the 2012 version and provides essential guidance on evaluating and managing the disease in all its facets. The new KDIGO ...

Chronic kidney disease (CKD) is a progressive condition that begins with tissue damage and gradually leads to loss of kidney function. The condition, which affects about 10% of the global population, ...

Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...

Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical ...

Kidney disease often progresses silently, causing irreversible damage before symptoms appear. Simple tests like blood ...

A major clinical trial showed such promising results that the drug’s maker halted it early. By Dani Blum Dani Blum has reported on Ozempic and similar drugs since 2022. Semaglutide, the compound in ...

Credit: Getty Images. Empagliflozin is a sodium-glucose co-transporter 2 inhibitor. The Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) to reduce the risk of sustained ...

Early detection of kidney disease is crucial for effective treatment, emphasizes KIMS Hospitals' leaders during a health awareness cyclothon.

Anemia in chronic kidney disease (CKD) causes the body to produce too few red blood cells. People with advanced kidney disease tend to develop this condition, and it can increase the risk of negative ...